Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the audited standalone ....
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences has informed exchanges that its Board meeting is scheduled for May 15, 2026 to consider and approve the audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2026. The company has also closed its trading window for designated persons effective April 1, 2026, reopening 48 hours after the results announcement. This is a routine regulatory intimation under SEBI Listing Regulations, providing advance notice ahead of the annual audited results release.
No direct impact from this filing alone. The actual impact on the stock will depend on the Q4 and full-year numbers when released on or after May 15, 2026. The closed trading window is standard practice and not a concern.